Skip to content

Electronic Respiratory Sound Monitoring System in Gastrointestinal Endoscopic Sedation

Impact of Implementing an Electronic Respiratory Sound Monitoring System for Quality Improvement in Gastrointestinal Endoscopic Sedation: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06938919
Enrollment
200
Registered
2025-04-22
Start date
2025-05-29
Completion date
2025-11-13
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic Retrograde Cholangiopancreatogram (ERCP), Gastrointestinal Endoscope

Keywords

Electronic repiratory sound monitoring system, Gstrointestinal endoscopic sedation

Brief summary

This study aims to evaluate the application of an electronic respiratory sound monitoring system during sedation for gastrointestinal endoscopy and to determine its effectiveness in improving sedation quality. Gastrointestinal endoscopy is a common medical procedure, but respiratory complications caused by sedation, such as hypoventilation and airway obstruction, are significant safety concerns. Traditional respiratory monitoring methods, such as end-tidal CO2 monitoring, are often unreliable due to difficulties in gas sampling during the procedure. In contrast, an electronic respiratory sound monitoring system can accurately capture tracheal breathing sounds and provide important parameters such as respiratory rate and airway obstruction ratio, helping clinicians avoid over-sedation. This study will conduct a randomized controlled trial with 120 participants, divided into a control group with conventional monitoring and an experimental group using the electronic respiratory sound monitoring system. The study will compare sedation dosage, airway complications, and recovery speed between the two groups, and further analyze the clinical value of the system's parameters. The findings of this study will contribute to improving the safety and precision of sedation during gastrointestinal endoscopy and provide evidence for future clinical guidelines.

Interventions

DEVICEroutine care without electronic respiratory sound monitoring system

Maintain heart rate between 50-100 bpm; maintain systolic blood pressure between 90-160 mmHg; maintain SpO2 above 94%.

DEVICEroutine care with electronic respiratory sound monitoring system

Maintain heart rate between 50-100 bpm; maintain systolic blood pressure between 90-160 mmHg; maintain SpO2 above 94%; and refer to the following electronic breath sound abnormalities to maintain sedation depth: Maintain respiratory rate (RR) at 12-20 bpm; avoid partial airway obstruction

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER
Metal Industries Research & Development Centre
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients who undergo routine colonoscopy plus gastroscopy or endoscopic retrograde cholangiopancreatography (ERCP) and require deep sedation

Exclusion criteria

* Pregnancy * Patients diagnosed with sleep apnea or morbid obesity (BMI greater than 40 kg/m2)

Design outcomes

Primary

MeasureTime frameDescription
Desaturationduring the procedureIncidence and duration of SpO2\< 94%

Secondary

MeasureTime frameDescription
Incidence of airway management for desaturationduring the procedurejaw thrust manuever, nasal airway insertion, mask ventilation
Total amount of anestheticsduring the procedureTotal amount of anesthetics used

Countries

Taiwan

Contacts

PRINCIPAL_INVESTIGATORKuang-Cheng Chan, M.D.,PhD.

Department of Anesthesiology, National Taiwan University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026